Cytokines associated with necrotizing enterocolitis in extremely-low-birth- weight infants

Pediatric Research

Volumn 76, Issue 1, 2014, Pages 100-108

  Maheshwari, Akhil ^a,b   Schelonka, Robert L ^a,c   Dimmitt, Reed A ^a   Carlo, Waldemar A ^a   Munoz Hernandez, Breda ^d   Das, Abhik ^d   McDonald, Scott A ^d   Thorsen, Poul ^e   Skogstrand, Kristin ^f   Hougaard, David M ^f   Higgins, Rosemary D ^g  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d RTI INTERNATIONAL   (United States)

^e KOLDING HOSPITAL   (Denmark)

^f STATENS SERUM INSTITUT   (Denmark)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROTROPHIN 4; RANTES; SOLUBLE INTERLEUKIN 6 RECEPTOR; STEROID; TRANSFORMING GROWTH FACTOR BETA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ETHNICITY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN PERIOD; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEPSIS; SEX DIFFERENCE; STEROID THERAPY;

BIOLOGICAL MARKERS; CYTOKINES; ENTEROCOLITIS, NECROTIZING; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; INTERLEUKIN-2; INTERLEUKIN-8; MALE; REPRODUCIBILITY OF RESULTS; RISK; TRANSFORMING GROWTH FACTOR BETA;

EID: 84902651586     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.48     Document Type: Article

References (40)

1. Stoll BJ, Hansen NI, Bell EF, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126:443-56.
2. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364: 255-64.
3. Viscardi RM, Lyon NH, Sun CC, Hebel JR, Hasday JD. Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine. Pediatr Pathol Lab Med 1997;17:547-59.
4. Harris MC, Costarino AT Jr, Sullivan JS, et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 1994;124:105-11.
5. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999;103:766-71.
6. Ng PC, Li K, Wong RP, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003;88:F209-13.
7. Benkoe T, Baumann S, Weninger M, et al. Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizing enterocolitis. PLoS One 2013;8:e58720.
8. Hsueh W, Caplan MS, Tan X, MacKendrick W, Gonzalez-Crussi F. Necrotizing enterocolitis of the newborn: pathogenetic concepts in perspective. Pediatr Dev Pathol 1998;1:2-16.
9. Maheshwari A. Role of cytokines in human intestinal villous development. Clin Perinatol 2004;31:143-55.
10. Schelonka RL, Maheshwari A, Carlo WA, et al.; NICHD Neonatal Research Network. T cell cytokines and the risk of blood stream infection in extremely low birth weight infants. Cytokine 2011;53:249-55.
11. Carlo WA, McDonald SA, Tyson JE, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokines and neurodevelopmental outcomes in extremely low birth weight infants. J Pediatr 2011;159:919-25.e3.
12. Maheshwari A, Kelly DR, Nicola T, et al. TGF-Â2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 2011;140:242-53.
13. Been JV, Rours IG, Kornelisse RF, et al. Histologic chorioamnionitis, fetal involvement, and antenatal steroids: effects on neonatal outcome in preterm infants. Am J Obstet Gynecol 2009;201:587.e1-8.
14. Andrews WW, Goldenberg RL, Faye-Petersen O, Cliver S, Goepfert AR, Hauth JC. The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. Am J Obstet Gynecol 2006;195:803-8.
15. Ambalavanan N, Carlo WA, DAngio CT, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009;123:1132-41.
16. Holman RC, Stoll BJ, Clarke MJ, Glass RI. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am J Public Health 1997;87:2026-31.
17. Guner YS, Friedlich P, Wee CP, Dorey F, Camerini V, Upperman JS. State-based analysis of necrotizing enterocolitis outcomes. J Surg Res 2009;157:21-9.
18. Chaaban H, Shin M, Sirya E, Lim YP, Caplan M, Padbury JF. Inter-Alpha inhibitor protein level in neonates predicts necrotizing enterocolitis. J Pediatr 2010;157:757-61.
19. Ng PC, Ang IL, Chiu RW, et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010;120:2989-3000.
20. Edelson MB, Sonnino RE, Bagwell CE, Lieberman JM, Marks WH, Rozycki HJ. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. J Pediatr Surg 1999;34:1453-7.
21. Lobe TE, Richardson CJ, Rassin DK, Mills R, Schwartz M. Hexosaminidase: a biochemical marker for necrotizing enterocolitis in the preterm infant. Am J Surg 1984;147:49-52.
22. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011;3:CD005496.
23. Quigley MA, Henderson G, Anthony MY, McGuire W. Formula milk versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2007;4:CD002971.
24. Namachivayam K, Blanco CL, MohanKumar K, et al. Smad7 inhibits autocrine expression of TGF-Â2 in intestinal epithelial cells in baboon necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2013;304: G167-80.
25. Wahl SM. Transforming growth factor-beta: innately bipolar. Curr Opin Immunol 2007;19:55-62.
26. Yoshinaga K, Obata H, Jurukovski V, et al. Perturbation of transforming growth factor (TGF)-beta1 association with latent TGF-beta binding protein yields inflammation and tumors. Proc Natl Acad Sci USA 2008;105:18758-63.
27. Dahle C, Kvarnstrom M, Ekerfelt C, Samuelsson M, Ernerudh J. Elevated number of cells secreting transforming growth factor beta in Guillain- Barré syndrome. APMIS 2003;111:1095-104.
28. Maheshwari A, Lacson A, Lu W, et al. Interleukin-8/CXCL8 forms an autocrine loop in fetal intestinal mucosa. Pediatr Res 2004;56:240-9.
29. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 2000;97:6043-8.
30. Mak JC, Leung HC, Sham AS, et al. Genetic polymorphisms and plasma levels of transforming growth factor-beta(1) in Chinese patients with tuberculosis in Hong Kong. Cytokine 2007;40:177-82.
31. Anttila A, Kauppinen H, Koivusalo A, Heikkila P, Savilahti E, Rintala R. T-cell-mediated mucosal immunity is attenuated in experimental necrotizing enterocolitis. Pediatr Surg Int 2003;19:326-30.
32. Pender SL, Braegger C, Gunther U, et al. Matrix metalloproteinases in necrotising enterocolitis. Pediatr Res 2003;54:160-4.
33. MohanKumar K, Kaza N, Jagadeeswaran R, et al. Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model. Am J Physiol Gastrointest Liver Physiol 2012;303:G93-102.
34. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003;6:6-23.
35. Ford HR, Sorrells DL, Knisely AS. Inflammatory cytokines, nitric oxide, and necrotizing enterocolitis. Semin Pediatr Surg 1996;5:155-9.
36. Sharma R, Tepas JJ 3rd, Hudak ML, et al. Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. J Pediatr Surg 2007;42:454-61.
37. Lodha A, Asztalos E, Moore AM. Cytokine levels in neonatal necrotizing enterocolitis and long-term growth and neurodevelopment. Acta Paediatr 2010;99:338-43.
38. Halpern MD, Clark JA, Saunders TA, et al. Reduction of experimental necrotizing enterocolitis with anti-TNF-Alpha. Am J Physiol Gastrointest Liver Physiol 2006;290:G757-64.
39. Skogstrand K, Ekelund CK, Thorsen P, et al. Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J Immunol Methods 2008;336:78-84.
40. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.